NL-OMON37438撤回不适用
CEFTRIAXONE NEONATAL THERAPY (CEFSINT) : A RANDOMIZED CONTROLLED TRIAL TO EVALUATE THE EFFECT OF CEFTRIAXONE ON HYPERBILIRUBINEMIA - CEFSINT
Sint Elisabeth Ziekenhuis0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 11（—）
入选标准
- •Neonates (0-28 days of age), presenting to the participating hospitals (EZ, TSZ) with serious bacterial infection requiring systemic antibiotic therapy.
排除标准
- •Gestational age < 34 weeks; severe congenital malformations; erythrocyte transfusion; blood group antagonism or other types of antibody antagonism; haemoglobinopathy; malignancy; serious perinatal asphyxia, concomitant use of intravenous calcium containing solutions (due to the risk of fatal calcium-CFT precipitations in blood vessels).
研究者
相似试验
进行中（未招募）
1 期
CEFTRIAXONE NEONATAL THERAPY: A RANDOMIZED CONTROLLED TRIAL TO EVALUATE THE EFFECT OF CEFTRIAXONE ON HYPERBILIRUBINEMIAHyperbilirubinemiaEUCTR2011-004417-16-NLSt. Elisabeth Hospital
已完成
不适用
The efficacy and safety evaluation of ceftriaxone and sulbactam combination (1.5 gram) in patients with skin and soft tissue infections: an open label, parallel, randomized, prospective comparative trialSkin and soft tissue infectionsInfections and InfestationsISRCTN76443564Ranbaxy Laboratories Ltd (India)400
进行中（未招募）
不适用
Efficacy assessment of ceftriaxone therapy in patients with amyotrophic lateral sclerosis. - NDAmyotrophic lateral sclerosis (ALS)MedDRA version: 6.1Level: PTClassification code 10002026EUCTR2007-004165-17-ITAZIENDA OSPEDALIERA PISANA
尚未招募
不适用
Study comparing antibiotics versus placebo at time of catheter removal post robotic prostate removalurinary tract infectionprostate cancerACTRN12619000768190A/Prof John Yaxley800
招募中
不适用
The clinical importance of the neonatal Fc receptor in RPE.NL-OMON32041Oogziekenhuis Rotterdam200